BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

VioQuest Pharmaceuticals, Inc. 

1981 Pine Hall Drive

State College  Pennsylvania  16801  U.S.A.
Phone: 814-234-5054 Fax: 814-234-3161


SEARCH JOBS




Industry
Pharmaceutical






 Company News
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Provides Strategic Alternatives Review, Announces Need for Capital and Potential Resignation of CEO, VP and CFO 10/27/2008 7:18:34 AM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Receives 510(k) Response from FDA for Xyfid(TM) 9/10/2008 6:33:20 AM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces Issuance of New U.S. Patent for Lenocta(TM) 8/26/2008 8:30:43 AM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces Second Quarter 2008 Financial Results and Corporate Highlights 8/19/2008 11:03:57 PM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB)' VQD-002 Named One of 10 Most Promising Oncology Projects by Windhover Information Inc. 7/30/2008 9:05:23 AM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Appoints Christopher P. Schnittker, CPA, as Chief Financial Officer 7/21/2008 10:10:41 AM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Submits 510(k) Application to FDA for Xyfid(TM), a Novel Topical Agent for the Treatment of Various Skin Disorders 7/1/2008 10:14:58 AM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Presents Phase 1 Data Showing Promising Immune Response and Safety Profile of Lenocta(TM) 6/2/2008 8:48:06 AM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces Upcoming Lenocta(TM) Oral Presentation at the American Society of Clinical Oncology Annual Meeting 5/19/2008 12:43:37 PM    More...
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces First Quarter 2008 Financial Results 5/15/2008 9:06:10 AM    More...
12345678910